What this is
Single filing record
This page shows the rows from one Form 4 filing as reported to the SEC.
Blue Collar Picks
Big buy
$3.6M open-market purchase by Baker Bros. Advisors (Gp) LLC, Director at Madrigal Pharmaceuticals,inc., filed August 20, 2025. Learn more
What this is
This page shows the rows from one Form 4 filing as reported to the SEC.
Why it matters
The original SEC document is the source record. Always verify before drawing conclusions.
How to read it
Insider activity carries more weight from senior officers, large dollar values, and clustered timing.
Stacked feeds
Baker Bros. Advisors (Gp) LLC · Director at Madrigal Pharmaceuticals,inc.
Baker Bros. Advisors (Gp) LLC bought $3.6M of MDGL (Madrigal Pharmaceuticals,inc.).
Insider purchase
Baker Bros. Advisors (Gp) LLC (Director) bought 9,477 shares of MDGL, Madrigal Pharmaceuticals,inc., Healthcare ($12.55B market cap), at $381.1216 per share on August 20, 2025 for a total of $3.6M (0.03% of the market cap).
Baker Bros. Advisors (Gp) LLC
Director
Permalink https://bluecollarpicks.com/insider-trading/MDGL/buy/26207
Market context
Last enriched August 6, 2026 at 8:07 AM EDT.
Filings
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?
| Ticker | Type & Role | Value | |
|---|---|---|---|
| This filing | Cluster Buy Director | $3.6M | |
Exercise and Hold CEO | Not reported | ||
| $17K | |||
| $17.2K | |||
| $17.5K | |||
| $34.2K | |||
| $34.8K | |||
| $34.9K | |||
| $50.2K | |||
| $51.7K | |||
| $68.6K | |||
| $69.5K | |||
| $179.3K | |||
| $279K | |||
| $0 | |||
| $0 | |||
Sell CEO | $718.3K | ||
Grant CEO | $0 | ||
Grant CEO | $0 | ||
Sell Officer | $155.5K | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Sell Officer | $181K | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Sell Director | $212.1K | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Sell CFO | $505.4K | ||
Exercise and Hold Director | Not reported | ||
Exercise and Hold Director | $18.4K | ||
Exercise and Hold Director | Not reported | ||
Exercise and Hold Director | $65.8K | ||
| $167.4K | |||
| $281.9K | |||
Sell CEO | $776.5K | ||
Sell Director | $318.6K | ||
| $129.1K | |||
| $215.1K | |||
Sell Director | $1.1M | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
| $4.4K | |||
| $154.3K | |||
| Not reported | |||
| $21.8K | |||
| $42.6K | |||
| $43K | |||
| $79.2K | |||
| $87.9K | |||
| $148.6K | |||
Selected filing
Select a row to inspect the filing.
Cluster detail
Ticker context
Recent insider activity for this company.
Insider detail
Recent transactions grouped by reporting owner.
Filters
Weekly recap
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →
Paid research tools
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.